Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: Bioarctic Says Leqembi-Data Suggests Potential To Delay Disease Progression

Dec 4 (Reuters) - BioArctic AB BIOAb.ST:

NEW LEQEMBI-DATA PRESENTED AT CTAD 2025 SUGGESTS POTENTIAL TO DELAY DISEASE PROGRESSION BY UP TO 8.3 YEARS WITH CONTINUED TREATMENT

Source text: ID:nWkr3mnfZJ

Further company coverage: BIOAb.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on BioArctic AB

See all news